Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
McKesson
Citi
QuintilesIMS
Johnson and Johnson
Express Scripts
Baxter
US Army
Merck
Cerilliant

Generated: August 18, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021266

« Back to Dashboard
NDA 021266 describes VFEND, which is a drug marketed by Pf Prism Cv and is included in three NDAs. It is available from three suppliers. There is one patent protecting this drug and three Paragraph IV challenges. Additional details are available on the VFEND profile page.

The generic ingredient in VFEND is voriconazole. There are thirteen drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the voriconazole profile page.

Summary for NDA: 021266

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Antifungals
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 021266

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
VFEND
voriconazole
TABLET;ORAL 021266 NDA Roerig 0049-3170 0049-3170-30 30 TABLET, FILM COATED in 1 BOTTLE (0049-3170-30)
VFEND
voriconazole
TABLET;ORAL 021266 NDA Roerig 0049-3180 0049-3180-30 30 TABLET, FILM COATED in 1 BOTTLE (0049-3180-30)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength50MG
Approval Date:May 24, 2002TE:ABRLD:Yes

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength200MG
Approval Date:May 24, 2002TE:ABRLD:Yes

Expired Orange Book Patents for NDA: 021266

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pf Prism Cv
VFEND
voriconazole
TABLET;ORAL021266-002May 24, 2002► Subscribe► Subscribe
Pf Prism Cv
VFEND
voriconazole
TABLET;ORAL021266-001May 24, 2002► Subscribe► Subscribe
Pf Prism Cv
VFEND
voriconazole
TABLET;ORAL021266-002May 24, 2002► Subscribe► Subscribe
Pf Prism Cv
VFEND
voriconazole
TABLET;ORAL021266-001May 24, 2002► Subscribe► Subscribe
Pf Prism Cv
VFEND
voriconazole
TABLET;ORAL021266-002May 24, 2002► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
Chubb
Fish and Richardson
Argus Health
Julphar
McKesson
US Army
Accenture
Moodys
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot